JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.21B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
Tesla
TSLA
|
+$1.1B |
| 4 |
NXP Semiconductors
NXPI
|
+$1.04B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$998M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.32B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 4 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.31B |
| 5 |
PayPal
PYPL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.77% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.83% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Banc of California
BANC
$3.13B
| $3.13M | ﹤0.01% |
159,357
+63,250
| +66% | +$1.28M |
|
|
RVNC
3327
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.13M | ﹤0.01% |
+191,600
| New | +$3.19M |
|
3328
CALL
Cigna
CI
$74.7B
| $3.12M | ﹤0.01% |
13,600
| – | – |
|
|
SUMO
3329
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $3.12M | ﹤0.01% |
230,108
-273,837
| -54% | -$4.25M |
|
3330
PUT
Best Buy
BBY
$18.2B
| $3.12M | ﹤0.01% |
30,700
| – | – |
|
|
YELL
3331
DELISTED
Yellow Corporation Common Stock
YELL
| $3.12M | ﹤0.01% |
247,492
+222,691
| +898% | +$2.43M |
|
3332
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.62B
| $3.12M | ﹤0.01% |
68,760
-15,356
| -18% | -$696K |
|
|
OPLN
3333
Openlane
OPLN
$4.36B
| $3.11M | ﹤0.01% |
199,257
-185,867
| -48% | -$2.85M |
|
3334
Transocean
RIG
$6.43B
| $3.11M | ﹤0.01% |
1,127,776
+562,176
| +99% | +$1.91M |
|
|
TPIC
3335
DELISTED
TPI Composites
TPIC
| $3.11M | ﹤0.01% |
207,628
-45,343
| -18% | -$1.11M |
|
|
CHAA
3336
DELISTED
Catcha Investment Corp
CHAA
| $3.11M | ﹤0.01% |
317,900
+260,000
| +449% | +$2.53M |
|
3337
Vermilion Energy
VET
$1.73B
| $3.1M | ﹤0.01% |
246,347
+116,024
| +89% | +$1.26M |
|
3338
Pacira BioSciences
PCRX
$917M
| $3.1M | ﹤0.01% |
51,538
+570
| +1% | +$31.4K |
|
|
BSX.PRA
3339
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $3.1M | ﹤0.01% |
+27,025
| New | +$3.08M |
|
3340
CALL
Teva Pharmaceuticals
TEVA
$42.8B
| $3.09M | ﹤0.01% |
385,700
-735,600
| -66% | -$6.64M |
|
3341
Oil States International
OIS
$539M
| $3.09M | ﹤0.01% |
621,048
-24,932
| -4% | -$147K |
|
|
STR
3342
DELISTED
Sitio Royalties
STR
| $3.09M | ﹤0.01% |
158,485
+10,480
| +7% | +$223K |
|
|
KBAL
3343
DELISTED
Kimball International
KBAL
| $3.07M | ﹤0.01% |
299,916
+17,204
| +6% | +$186K |
|
3344
CareDx
CDNA
$2.34B
| $3.07M | ﹤0.01% |
67,411
-28,645
| -30% | -$1.5M |
|
|
BFS
3345
Saul Centers
BFS
$860M
| $3.06M | ﹤0.01% |
57,789
-3,113
| -5% | -$155K |
|
|
BRG
3346
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $3.06M | ﹤0.01% |
115,949
+115,791
| +73,285% | +$1.84M |
|
|
AZRE
3347
DELISTED
Azure Power Global Limited
AZRE
| $3.06M | ﹤0.01% |
168,371
-11,041
| -6% | -$233K |
|
|
KNBE
3348
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $3.06M | ﹤0.01% |
133,179
+118,810
| +827% | +$2.79M |
|
3349
United Parks & Resorts
PRKS
$2.04B
| $3.05M | ﹤0.01% |
46,964
-35,888
| -43% | -$2.26M |
|
3350
Southside Bancshares
SBSI
$986M
| $3.04M | ﹤0.01% |
72,736
+60,421
| +491% | +$2.5M |
|
Similar funds
JP Morgan Chase's Q4 2021 Portfolio in Review
As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
- JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
- JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
- JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
- JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
- JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.